Libra Infusions (DHA:LIBRAINFU) Marketable Securities: BDT0.00 Mil (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DHA:LIBRAINFU Libra Infusions Ltd DHA:LIBRAINFU
21 GF Score
Price BDT637.10
View Full Analysis

What is Libra Infusions Marketable Securities?

Libra Infusions DHA:LIBRAINFU -0.44% 21 Marketable Securities is BDT0.00 Mil as of . 20. GuruFocus rates DHA:LIBRAINFU with a GF Score™ of 21/100.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Libra Infusions's Marketable Securities for the quarter that ended in . 20 was BDT0.00 Mil.

Libra Infusions  (DHA:LIBRAINFU) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Libra Infusions Marketable Securities Related Terms

Libra Infusions Marketable Securities Historical Data

* Premium members only.

The historical data trend for Libra Infusions's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Libra Infusions Marketable Securities Chart

Libra Infusions Annual Data
Trend
Marketable Securities

Libra Infusions Semi-Annual Data
Marketable Securities
DHA:LIBRAINFU
21GF Score
Libra Infusions Ltd DHA:LIBRAINFU
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Libra Infusions Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of BDT0.00 Mil mean?
Libra Infusions (DHA:LIBRAINFU) has a Marketable Securities of BDT0.00 Mil as of . 20. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Libra Infusions and its competitors.
Is Libra Infusions' Marketable Securities too high?
Libra Infusions' current Marketable Securities is BDT0.00 Mil. Overall, Libra Infusions has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Libra Infusions' Marketable Securities compare to SECI and LENSF?
Libra Infusions' Marketable Securities of BDT0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Medical Devices & Instruments company?
A good Marketable Securities depends on the Medical Devices & Instruments industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Libra Infusions and its competitors. Libra Infusions's current Marketable Securities is BDT0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Libra Infusions stock overvalued right now?
Libra Infusions (DHA:LIBRAINFU) has a current Marketable Securities of BDT0.00 Mil. The current Marketable Securities is BDT0.00 Mil. Libra Infusions' overall GF Score™ is 21/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Libra Infusions (DHA:LIBRAINFU), the current Marketable Securities is BDT0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Libra Infusions Business Description

Address I/7, Mirpur Industrial Estate, Rupnagar, Section-2, Dhaka, BGD, 1216
Libra Infusions Ltd is engaged in manufacturing intravenous fluids. It provides products which are used for medical purposes involving surgical operations, loss of blood, weakness, and general hospitalization.
21GF Score

Get the complete analysis for DHA:LIBRAINFU

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT637.10
Price